Utilization of an intracellular bacterial community pathway in Klebsiella pneumoniae urinary tract infection and the effects of FimK on type 1 pilus expression.

Infection and Immunity
David A RosenScott J Hultgren

Abstract

Klebsiella pneumoniae is an important cause of urinary tract infection (UTI), but little is known about its pathogenesis in vivo. The pathogenesis of the K. pneumoniae cystitis isolate TOP52 was compared to that of the uropathogenic Escherichia coli (UPEC) isolate UTI89 in a murine cystitis model. Bladder and kidney titers of TOP52 were lower than those of UTI89 at early time points but similar at later time points. TOP52, like UTI89, formed biofilm-like intracellular bacterial communities (IBCs) within the murine bladder, albeit at significantly lower levels than UTI89. Additionally, filamentation of TOP52 was observed, a process critical for UTI89 evasion of neutrophil phagocytosis and persistence in the bladder. Thus, the IBC pathway is not specific to UPEC alone. We investigated if differences in type 1 pilus expression may explain TOP52's early defect in vivo. The type 1 pilus operon is controlled by recombinase-mediated (fimE, fimB, and fimX) phase variation of an invertible promoter element. We found that K. pneumoniae carries an extra gene of unknown function at the 3' end of its type 1 operon, fimK, and the genome lacks the recombinase fimX. A deletion mutant of fimK was constructed, and TOP52 Delta fimK had higher tit...Continue Reading

References

Feb 9, 1978·The New England Journal of Medicine·R M BuckleyR R MacGregor
Mar 1, 1992·The Journal of Infection·W C LyeG Kumarasinghe
Jan 2, 1991·JAMA : the Journal of the American Medical Association·T M HootonW E Stamm
Mar 1, 1991·The Medical Clinics of North America·A R Ronald, A L Pattullo
Jul 1, 1990·Reviews of Infectious Diseases·J L Carpenter
May 1, 1985·Journal of Bacteriology·K BuchananS I Hull
Mar 23, 1972·The New England Journal of Medicine·J L BranD Kaye
Nov 4, 1969·Journal of Medical Microbiology·J P Duguid, I Campbell
Nov 1, 1980·Infection and Immunity·R C Fader, C P Davis
Aug 15, 1996·The New England Journal of Medicine·T M HootonW E Stamm
Sep 3, 1996·Proceedings of the National Academy of Sciences of the United States of America·X R WuJ J Medina
Oct 6, 1997·Infectious Disease Clinics of North America·T M Hooton, W E Stamm
Jun 1, 2000·Proceedings of the National Academy of Sciences of the United States of America·K A Datsenko, B L Wanner
Jun 17, 2000·The EMBO Journal·J J MartinezS J Hultgren
Apr 11, 2001·International Journal of Antimicrobial Agents·A Ronald, E Ludwig
Apr 11, 2001·International Journal of Antimicrobial Agents·A R RonaldV Andriole
Feb 22, 2002·Cellular Microbiology·Juan J Martinez, Scott J Hultgren
Jul 13, 2002·The American Journal of Medicine·Betsy Foxman
Jul 5, 2003·Science·Gregory G AndersonScott J Hultgren
Dec 16, 2003·BMC Molecular Biology·Kenan C Murphy, Kenneth G Campellone
Jan 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·Sheryl S JusticeScott J Hultgren
Jul 17, 2004·Molecular Microbiology·Anna D Tischler, Andrew Camilli
Oct 2, 2004·Molecular Microbiology·Begoña GarcíaIñigo Lasa
Aug 6, 2005·The Journal of Biological Chemistry·Rita TamayoAndrew Camilli

❮ Previous
Next ❯

Citations

Sep 26, 2013·Mucosal Immunology·M A Ingersoll, M L Albert
Aug 1, 2009·Nature Protocols·Chia-Suei HungScott J Hultgren
Dec 17, 2008·Nucleic Acids Research·Charles J Dorman, Colin P Corcoran
Dec 2, 2009·Applied and Environmental Microbiology·Jeffrey J MargolisDenise M Monack
Jul 23, 2008·Infection and Immunity·David A RosenScott J Hultgren
Jun 6, 2009·Future Microbiology·R Brock Neil, Michael A Apicella
Aug 25, 2012·Indian Journal of Urology : IJU : Journal of the Urological Society of India·Dennis J HorvathSheryl S Justice
Aug 24, 2012·Future Microbiology·Caitlin N Murphy, Steven Clegg
Jul 6, 2014·Genome Announcements·Jeremiah G JohnsonJyl S Matson
Sep 10, 2010·Annual Review of Microbiology·David A Hunstad, Sheryl S Justice
Sep 9, 2015·The Journal of Infectious Diseases·David A RosenDavid A Hunstad
Jun 28, 2011·Journal of Microbiological Methods·Jon Jurriaan van Aartsen, Kumar Rajakumar
Oct 18, 2015·The Urologic Clinics of North America·Maxim J McKibbenKristy M Borawski
Apr 21, 2009·Cellular Microbiology·Luanne Hall-Stoodley, Paul Stoodley
Jan 21, 2012·Microbiology·Chien-Chen WuHwei-Ling Peng
May 25, 2013·Microbiology·Zhe-Chong WangHwei-Ling Peng
Feb 14, 2015·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·M BodroC Cervera
Mar 28, 2012·FEMS Immunology and Medical Microbiology·Steen G StahlhutAndreas Reisner
May 4, 2010·Microbes and Infection·Birong LiSheryl S Justice
Sep 6, 2008·Microbial Pathogenesis·Rahul MittalKusum Harjai
Jul 17, 2012·The American Journal of Pathology·Jacqueline C BouchardDaniel G Remick
Dec 2, 2014·Pathogens·Claudia VuottoPietro E Varaldo
Oct 5, 2017·International Journal of Molecular Sciences·Allison R EberlyMaria Hadjifrangiskou
Dec 23, 2017·Transplant Infectious Disease : an Official Journal of the Transplantation Society·Ian Hollyer, Michael G Ison
Nov 22, 2017·Infection and Immunity·David A RosenDavid A Hunstad
Nov 1, 2016·Nature Microbiology·Valerie P O'BrienScott J Hultgren

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.